EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,466 | -79.8% | 410 | -75.2% | 0.00% | – |
| Q2 2023 | $32,076 | +267200.0% | 1,650 | +302.4% | 0.00% | – |
| Q1 2023 | $12 | 0.0% | 410 | 0.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 410 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -51.9% | 410 | -33.5% | 0.00% | – |
| Q2 2022 | $27,000 | 0.0% | 617 | +12.8% | 0.00% | – |
| Q1 2022 | $27,000 | -81.0% | 547 | -82.3% | 0.00% | -100.0% |
| Q4 2021 | $142,000 | -16.0% | 3,085 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $169,000 | -11.5% | 3,035 | -32.1% | 0.00% | 0.0% |
| Q2 2021 | $191,000 | -16.2% | 4,472 | -18.3% | 0.00% | 0.0% |
| Q1 2021 | $228,000 | -10.6% | 5,472 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $255,000 | +152.5% | 5,472 | +130.5% | 0.00% | +100.0% |
| Q3 2020 | $101,000 | – | 2,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 400,000 | $5,732,000 | 1.52% |
| Park West Asset Management LLC | 426,900 | $6,117,000 | 0.80% |
| WALL STREET ASSOCIATES | 200,000 | $2,866,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 284,653 | $4,079,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 100,000 | $1,433,000 | 0.02% |
| NEXT Financial Group, Inc | 2,500 | $26,000 | 0.01% |
| PIPER SANDLER & CO. | 1,277 | $18,000 | 0.01% |
| Ground Swell Capital, LLC | 400 | $6,000 | 0.01% |
| PARADIGM ASSET MANAGEMENT CO LLC | 6,300 | $90,279,000 | 0.01% |
| Paloma Partners Management Co | 14,363 | $206,000 | 0.01% |